Clinical Trial: A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07235384) titled 'A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis' on Nov. 14.

Brief Summary: This is a phase 1/1b randomized, double blind, placebo-controlled, single dose escalation (SAD) and multiple dose escalation (MAD) study to evaluate the safety, tolerability, and pharmacokinetics (PK) of ZL-1503 in healthy volunteers and participants with moderate to severe atopic dermatitis (AD)

Study Start Date: Dec. 04

Study Type: INTERVENTIONAL

Condition: Atopic Dermatitis (AD)

Intervention: DRUG: ZL-1503

Healthy volunteers will rec...